270 related articles for article (PubMed ID: 15929773)
21. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.
Chen-Shtoyerman R; Figer A; Fidder HH; Rath P; Yeremin L; Bar Meir S; Friedman E; Theodor L
Br J Cancer; 2001 Feb; 84(4):475-7. PubMed ID: 11207040
[TBL] [Abstract][Full Text] [Related]
22. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
23. The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews.
Boursi B; Sella T; Liberman E; Shapira S; David M; Kazanov D; Arber N; Kraus S
Eur J Cancer; 2013 Nov; 49(17):3680-5. PubMed ID: 23896379
[TBL] [Abstract][Full Text] [Related]
24. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.
Kapitanović S; Cacev T; Radosević S; Spaventi S; Spaventi R; Pavelić K
Exp Mol Pathol; 2004 Dec; 77(3):193-200. PubMed ID: 15507235
[TBL] [Abstract][Full Text] [Related]
25. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
[TBL] [Abstract][Full Text] [Related]
26. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features.
Locker GY; Kaul K; Weinberg DS; Gatalica Z; Gong G; Peterman A; Lynch J; Klatzco L; Olopade OI; Bomzer CA; Newlin A; Keenan E; Tajuddin M; Knezetic J; Coronel S; Lynch HT
Cancer Genet Cytogenet; 2006 Aug; 169(1):33-8. PubMed ID: 16875934
[TBL] [Abstract][Full Text] [Related]
27. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.
Laken SJ; Petersen GM; Gruber SB; Oddoux C; Ostrer H; Giardiello FM; Hamilton SR; Hampel H; Markowitz A; Klimstra D; Jhanwar S; Winawer S; Offit K; Luce MC; Kinzler KW; Vogelstein B
Nat Genet; 1997 Sep; 17(1):79-83. PubMed ID: 9288102
[TBL] [Abstract][Full Text] [Related]
28. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.
Woodage T; King SM; Wacholder S; Hartge P; Struewing JP; McAdams M; Laken SJ; Tucker MA; Brody LC
Nat Genet; 1998 Sep; 20(1):62-5. PubMed ID: 9731533
[TBL] [Abstract][Full Text] [Related]
29. Somatic instability of the APC I1307K allele in colorectal neoplasia.
Gryfe R; Di Nicola N; Gallinger S; Redston M
Cancer Res; 1998 Sep; 58(18):4040-3. PubMed ID: 9751605
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps.
Syngal S; Schrag D; Falchuk M; Tung N; Farraye FA; Chung D; Wright M; Whetsell A; Miller G; Garber JE
JAMA; 2000 Aug; 284(7):857-60. PubMed ID: 10938175
[TBL] [Abstract][Full Text] [Related]
31. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
Levine DA; Argenta PA; Yee CJ; Marshall DS; Olvera N; Bogomolniy F; Rahaman JA; Robson ME; Offit K; Barakat RR; Soslow RA; Boyd J
J Clin Oncol; 2003 Nov; 21(22):4222-7. PubMed ID: 14615451
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Scand J Gastroenterol; 2007 May; 42(5):628-32. PubMed ID: 17454884
[TBL] [Abstract][Full Text] [Related]
33. The I1307K APC mutation in a high-risk clinic setting: a follow-up study.
Regev M; Barzilai SE; Figer A; Zidan J; Fidder HH; Friedman E
Clin Genet; 2005 Apr; 67(4):352-5. PubMed ID: 15733272
[TBL] [Abstract][Full Text] [Related]
34. APC E1317Q is not associated with Colorectal Cancer in a population-based case-control study in Northern Israel.
Rozek LS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2325-7. PubMed ID: 17119068
[TBL] [Abstract][Full Text] [Related]
35. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
[TBL] [Abstract][Full Text] [Related]
36. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer.
Diergaarde B; Braam H; Vasen HF; Nagengast FM; van Muijen GN; Kok FJ; Kampman E
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):736-42. PubMed ID: 17544999
[TBL] [Abstract][Full Text] [Related]
37. Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects.
Abdel-Malak C; Darwish H; Elsaid A; El-Tarapely F; Elshazli R
Fam Cancer; 2016 Jan; 15(1):49-56. PubMed ID: 26314409
[TBL] [Abstract][Full Text] [Related]
38. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
39. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA
Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604
[TBL] [Abstract][Full Text] [Related]
40. A636P testing in Ashkenazi Jews.
Guillem JG; Moore HG; Palmer C; Glogowski E; Finch R; Nafa K; Markowitz AJ; Offit K; Ellis NA
Fam Cancer; 2004; 3(3-4):223-7. PubMed ID: 15516845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
